Journal article icon

Journal article

Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies

Abstract:
After nearly four decades of research, a safe and effective HIV-1 vaccine remains elusive. There are many reasons why the development of a potent and durable HIV-1 vaccine is challenging, including the extraordinary genetic diversity of HIV-1 and its complex mechanisms of immune evasion. HIV-1 envelope glycoproteins are poorly recognized by the immune system, which means that potent broadly neutralizing antibodies (bnAbs) are only infrequently induced in the setting of HIV-1 infection or through vaccination. Thus, the biology of HIV-1–host interactions necessitates novel strategies for vaccine development to be designed to activate and expand rare bnAb-producing B cell lineages and to select for the acquisition of critical improbable bnAb mutations. Here we discuss strategies for the induction of potent and broad HIV-1 bnAbs and outline the steps that may be necessary for ultimate success.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1038/s41577-022-00753-w

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Role:
Author
ORCID:
0000-0002-3877-9780


Publisher:
Springer Nature
Journal:
Nature Reviews Immunology More from this journal
Volume:
23
Issue:
3
Pages:
142-158
Publication date:
2022-08-12
Acceptance date:
2022-06-15
DOI:
EISSN:
1474-1741
ISSN:
1474-1733


Language:
English
Keywords:
Pubs id:
1264225
Local pid:
pubs:1264225
Deposit date:
2022-06-20

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP